# PREDNISONE
> **ANDA212629** · Abbreviated New Drug Application (Generic) · Sponsor: POINTVIEW HLDINGS · Approved 2023-12-05
## Drug
- **FDA Application Number:** ANDA212629
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PREDNISONE
- **Generic name:** PREDNISONE
- **Active ingredients:** PREDNISONE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** POINTVIEW HLDINGS
- **Manufacturer:** Granulation Technology, Inc.
- **First approval:** 2023-12-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212629)
---
*AI Analytics · CC0 1.0*